CPT code 81599 denotes a multianalyte assay with algorithmic analysis (MAAA) when no specific Category I code or Appendix O administrative code exists. Nationally, this code is important for reporting complex, algorithm-driven laboratory tests used in diagnostics, prognostics, and therapeutic decision support across clinical specialties. Its use affects billing, coverage determinations, and visibility of advanced laboratory services.

Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of how 81599 is applied, payer coverage considerations, and typical sites of service for MAAA testing. The publication summarizes common modifiers associated with laboratory and professional billing, and describes the implications of using an unlisted multianalyte code when no specific code exists.

The report provides benchmarks and policy context relevant to payers and providers, including coding practice, documentation expectations, and references to administrative coding guidance. It also outlines what clinicians and billing staff should document when ordering or submitting claims for MAAA testing and highlights areas where payers commonly request additional clinical or technical information. Data not available in the input is noted where applicable.